US-based Znomics has appointed Ofir Moreno as its new senior director of chemistry, a newly created position.
Subscribe to our email newsletter
Dr Moreno has held research positions at Merck, Amgen, Corvas International, and Dendreon where he served as senior director of chemistry.
Dr Moreno has received his doctorate in organic chemistry from Harvard University where he worked with professor Yoshito Kishi and a dual Bachelor of Arts degree in chemistry and biology from Cornell University.
Bruce Beutel, chief scientific officer of Znomics, said: “We are all very excited to have Ofir join our drug discovery team. He brings a depth of experience leading outsourced medicinal chemistry programs, ranging from concept to clinical candidate, including everything from creating intellectual property, formulating chemistry strategy, interfacing with biologists, negotiating external contracts, writing patents, and contributing to business development.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.